Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 4:41 pm Purchase | 13G | Tarsus Pharmaceuticals Inc. TARS | PRUDENTIAL FINANCIAL INC PRU | 2,295,400 6.000% | 2,295,400 (New Position) | View |
| 2024-11-14 4:35 pm Purchase | 13G | Tarsus Pharmaceuticals Inc. TARS | Paradigm Biocapital Advisors LP | 2,440,445 6.400% | 512,939 (+26.61%) | View |
| 2024-11-14 3:05 pm Sale | 13G | Tarsus Pharmaceuticals Inc. TARS | Cormorant Asset Management LP | 500,000 1.310% | -1,721,422 (-77.49%) | View |
| 2024-11-12 6:02 pm Unchanged | 13G | Tarsus Pharmaceuticals Inc. TARS | VANGUARD GROUP INC | 2,097,323 5.510% | 0 (Unchanged) | View |
| 2024-11-12 09:12 am Purchase | 13G | Tarsus Pharmaceuticals Inc. TARS | JENNISON ASSOCIATES LLC | 2,178,580 5.700% | 2,178,580 (New Position) | View |
| 2024-11-08 5:31 pm Unchanged | 13G | Tarsus Pharmaceuticals Inc. TARS | BlackRock Inc. | 3,755,504 9.900% | 0 (Unchanged) | View |
| 2024-11-06 10:26 am Purchase | 13G | Tarsus Pharmaceuticals Inc. TARS | Frazier Life Sciences IX L.P. | 1,587,527 4.200% | 170,370 (+12.02%) | View |
| 2024-11-04 2:00 pm Purchase | 13G | Tarsus Pharmaceuticals Inc. TARS | VANGUARD GROUP INC | 2,097,323 5.510% | 2,097,323 (New Position) | View |
| 2024-10-21 4:11 pm Purchase | 13G | Tarsus Pharmaceuticals Inc. TARS | BlackRock Inc. | 3,755,504 9.900% | 3,755,504 (New Position) | View |
| 2024-02-14 4:00 pm Purchase | 13G | Tarsus Pharmaceuticals Inc. TARS | TANG CAPITAL PARTNERS LP | 2,204,797 6.700% | 203,212 (+10.15%) | View |
| 2024-02-14 3:04 pm Purchase | 13G | Tarsus Pharmaceuticals Inc. TARS | Cormorant Asset Management LP | 2,221,422 6.710% | 485,000 (+27.93%) | View |
| 2024-02-14 07:28 am Purchase | 13G | Tarsus Pharmaceuticals Inc. TARS | RTW INVESTMENTS LP | 3,152,341 9.500% | 604,216 (+23.71%) | View |
| 2024-02-13 5:03 pm Sale | 13G | Tarsus Pharmaceuticals Inc. TARS | Vivo Capital IX LLC | 894,826 2.700% | -1,367,374 (-60.44%) | View |
| 2024-02-09 10:06 am Purchase | 13G | Tarsus Pharmaceuticals Inc. TARS | MORGAN STANLEY MS | 1,943,705 5.900% | 1,943,705 (New Position) | View |
| 2024-02-02 12:40 pm Purchase | 13G | Tarsus Pharmaceuticals Inc. TARS | Cowen Financial Products LLC | 1,911,399 5.770% | 512,416 (+36.63%) | View |
| 2024-02-02 06:05 am Sale | 13G | Tarsus Pharmaceuticals Inc. TARS | TimesSquare Capital Management LLC | 0 0.000% | -1,429,310 (Position Closed) | View |
| 2024-01-26 11:49 am Purchase | 13G | Tarsus Pharmaceuticals Inc. TARS | BlackRock Inc. BLK | 2,515,124 7.600% | 1,188,593 (+89.60%) | View |
| 2024-01-22 5:05 pm Purchase | 13G | Tarsus Pharmaceuticals Inc. TARS | Paradigm Biocapital Advisors LP | 1,927,506 5.800% | 1,927,506 (New Position) | View |
| 2023-05-05 3:28 pm Purchase | 13G | Tarsus Pharmaceuticals Inc. TARS | Cowen Financial Products LLC | 1,398,983 5.220% | 1,398,983 (New Position) | View |
| 2023-02-14 4:00 pm Sale | 13G | Tarsus Pharmaceuticals Inc. TARS | TANG CAPITAL PARTNERS LP | 2,001,585 7.500% | -90,168 (-4.31%) | View |